John Maraganore, Alnylam CEO (Scott Eisen/Bloomberg via Getty Images)
Alnylam gets the green light from the FDA for drug #3 — and CEO John Maraganore is ready to roll
Score another early win at the FDA for Alnylam.
The FDA put out word today that the agency has approved …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
